Ángel D. Hernández-Mejías
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ángel D. Hernández-Mejías has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Alex Shimozono
The Warren and Katharine Schlinger Laboratory for Chemistry and Chemical Engineering, Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, United States
2 shared publications - Andrew T. Parsons
Process Development, Amgen, Inc., Cambridge, Massachusetts 02142, United States
2 shared publications - Kyle Quasdorf
Drug Substance Technologies - Synthetics, Process Development, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States
2 shared publications - Matthew S. Sigman
University of Utah
2 shared publications - Sarah E. Reisman
California Institute of Technology
2 shared publications Avijit Hazra
Department of Chemistry, University of Utah, Salt Lake City, Utah 84112, United States
1 shared publication
Latest Publications
- 16 July 2025
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 88 (7) , 1701-1709
In Silico Design and Analysis of Cyanobacterial Pseudo Natural Products
Marine cyanobacteria produce natural products (NPs) with potent and selective bioactivity against a broad range of diseases. However, like many NPs, most exhibit poor drug-like physicochemical properties, and the discovery of structurally novel NPs is declining. To address these challenges, we generated an in silico library of 2,415 cyanobacterial pseudo-NPs by tethering cyanobacterial NP fragments with privileged scaffolds from noncyanobacterial NPs via hypothetical amide bond formation. This library was analyzed using computational platforms to assess predicted physicochemical and ADME/Tox properties, lead-likeness penalties, NP-likeness scores, Tanimoto similarity coefficients, and Synthetic Accessibility Scores. Comparisons to public compound libraries showed that most cyanobacterial pseudo-NPs possess favorable drug- and lead-like characteristics; occupy low-density chemical space; and display unique, synthetically accessible scaffolds. Our results suggest that these pseudo-NPs are promising synthetic targets for drug development. Moreover, this platform can be expanded by using artificial intelligence (AI)-based fragment harvesting tools to create larger libraries of NP-inspired compounds. By integrating cyanobacterial fragments with known bioactive motifs, we aim to bridge the gap between natural diversity and drug-like properties, providing a novel and tractable chemical space for drug discovery efforts.
- 16 July 2025
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 88 (7) , 1701-1709
In Silico Design and Analysis of Cyanobacterial Pseudo Natural Products
Marine cyanobacteria produce natural products (NPs) with potent and selective bioactivity against a broad range of diseases. However, like many NPs, most exhibit poor drug-like physicochemical properties, and the discovery of structurally novel NPs is declining. To address these challenges, we generated an in silico library of 2,415 cyanobacterial pseudo-NPs by tethering cyanobacterial NP fragments with privileged scaffolds from noncyanobacterial NPs via hypothetical amide bond formation. This library was analyzed using computational platforms to assess predicted physicochemical and ADME/Tox properties, lead-likeness penalties, NP-likeness scores, Tanimoto similarity coefficients, and Synthetic Accessibility Scores. Comparisons to public compound libraries showed that most cyanobacterial pseudo-NPs possess favorable drug- and lead-like characteristics; occupy low-density chemical space; and display unique, synthetically accessible scaffolds. Our results suggest that these pseudo-NPs are promising synthetic targets for drug development. Moreover, this platform can be expanded by using artificial intelligence (AI)-based fragment harvesting tools to create larger libraries of NP-inspired compounds. By integrating cyanobacterial fragments with known bioactive motifs, we aim to bridge the gap between natural diversity and drug-like properties, providing a novel and tractable chemical space for drug discovery efforts.
- Open Access
- 14 January 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (4) , 3468-3477
Ni-Catalyzed Enantioselective Desymmetrization: Development of Divergent Acyl and Decarbonylative Cross-Coupling Reactions
Ni-catalyzed asymmetric reductive cross-coupling reactions provide rapid and modular access to enantioenriched building blocks from simple electrophile precursors. Reductive coupling reactions that can diverge through a common organometallic intermediate to two distinct families of enantioenriched products are particularly versatile but underdeveloped. Here, we describe the development of a bis(oxazoline) ligand that enables the desymmetrization of meso-anhydrides. When secondary benzylic electrophiles are employed, doubly stereoselective acyl cross-coupling proceeds to give ketone products with catalyst control over three newly formed stereogenic centers. Alternatively, the use of primary alkyl halides in the presence of an additional halogen atom transfer catalyst results in decarbonylative alkylation to give enantioenriched β-alkyl acids. Analysis of reaction rates for a range of both catalysts and substrates supports the notion that tuning the different electrophile activation steps with the two catalysts is required for enhanced reaction performance. These studies illustrate how reaction design can diverge a common Ni-acyl intermediate to either acyl or decarbonylative coupling products and highlight how dual ligand systems can be used to engage unactivated alkyl halides in Ni-catalyzed asymmetric reductive coupling.
- 14 January 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (4) , 3468-3477
Open AccessNi-Catalyzed Enantioselective Desymmetrization: Development of Divergent Acyl and Decarbonylative Cross-Coupling Reactions
Ni-catalyzed asymmetric reductive cross-coupling reactions provide rapid and modular access to enantioenriched building blocks from simple electrophile precursors. Reductive coupling reactions that can diverge through a common organometallic intermediate to two distinct families of enantioenriched products are particularly versatile but underdeveloped. Here, we describe the development of a bis(oxazoline) ligand that enables the desymmetrization of meso-anhydrides. When secondary benzylic electrophiles are employed, doubly stereoselective acyl cross-coupling proceeds to give ketone products with catalyst control over three newly formed stereogenic centers. Alternatively, the use of primary alkyl halides in the presence of an additional halogen atom transfer catalyst results in decarbonylative alkylation to give enantioenriched β-alkyl acids. Analysis of reaction rates for a range of both catalysts and substrates supports the notion that tuning the different electrophile activation steps with the two catalysts is required for enhanced reaction performance. These studies illustrate how reaction design can diverge a common Ni-acyl intermediate to either acyl or decarbonylative coupling products and highlight how dual ligand systems can be used to engage unactivated alkyl halides in Ni-catalyzed asymmetric reductive coupling.
- Open Access
- 24 September 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Ni-Catalyzed Enantioselective Desymmetrization: Development of Divergent Acyl and Decarbonylative Cross-Coupling Reactions
Ni-catalyzed asymmetric reductive cross-coupling reactions provide rapid and modular access to enantioenriched building blocks from simple electrophile precursors. Reductive coupling reactions that can diverge through a common organometallic intermediate to two distinct families of enantioenriched products are particularly versatile but underdeveloped. Here, we describe the development of a bis(oxazoline) ligand that enables the desymmetrization of meso-anhydrides. When secondary benzylic electrophiles are employed, doubly stereoselective acyl cross-coupling proceeds to give ketone products with catalyst control over three newly formed stereogenic centers. Alternatively, use of primary alkyl halides in the presence of an additional halogen atom transfer catalyst results in decarbonylative alkylation to give enantioenriched beta-alkyl acids. Analysis of reaction rates for a range of both catalysts and substrates supports the notion that tuning the different electrophile activation steps with the two catalysts is required for enhanced reaction performance. These studies illustrate how reaction design can diverge a common Ni-acyl intermediate to either acyl or decarbonylative coupling products and highlight how dual ligand systems can be used to engage unactivated alkyl halides in Ni-catalyzed asymmetric reductive coupling.
- 24 September 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessNi-Catalyzed Enantioselective Desymmetrization: Development of Divergent Acyl and Decarbonylative Cross-Coupling Reactions
Ni-catalyzed asymmetric reductive cross-coupling reactions provide rapid and modular access to enantioenriched building blocks from simple electrophile precursors. Reductive coupling reactions that can diverge through a common organometallic intermediate to two distinct families of enantioenriched products are particularly versatile but underdeveloped. Here, we describe the development of a bis(oxazoline) ligand that enables the desymmetrization of meso-anhydrides. When secondary benzylic electrophiles are employed, doubly stereoselective acyl cross-coupling proceeds to give ketone products with catalyst control over three newly formed stereogenic centers. Alternatively, use of primary alkyl halides in the presence of an additional halogen atom transfer catalyst results in decarbonylative alkylation to give enantioenriched beta-alkyl acids. Analysis of reaction rates for a range of both catalysts and substrates supports the notion that tuning the different electrophile activation steps with the two catalysts is required for enhanced reaction performance. These studies illustrate how reaction design can diverge a common Ni-acyl intermediate to either acyl or decarbonylative coupling products and highlight how dual ligand systems can be used to engage unactivated alkyl halides in Ni-catalyzed asymmetric reductive coupling.
- Open Access
- 20 November 2023
- Published by American Chemical Society (ACS) in ChemRxiv
2-Aminophenanthrolines Enable the Mild, Undirected Borylation of Alkyl C–H Bonds
The catalytic, undirected borylation of alkyl C–H bonds typically occurs at high reaction temperatures or with excess substrate, or both, because of the low reactivity of alkyl C–H bonds. Here we report a new iridium system comprising 2-anilino-1,10-phenanthroline as ligand that catalyzes the borylation of alkyl C–H bonds with little to no induction period and with high reaction rates. This superior activation and reactivity profile of 2-aminophenanthroline catalysts leads to broader scope of the reaction, including those with sensitive reactants, such as epoxides and glycosidic acetals, enhanced diastereoselectivity, and higher yields of borylated products. These catalysts also enable the borylation of alkanes, amines, and ethers at room temperature for the first time. Mechanistic studies imply that facile N-borylation occurs under the reaction conditions, and that iridium complexes containing N-boryl aminophenanthrolines are competent precatalysts for the reaction.
- 20 November 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Open Access2-Aminophenanthrolines Enable the Mild, Undirected Borylation of Alkyl C–H Bonds
The catalytic, undirected borylation of alkyl C–H bonds typically occurs at high reaction temperatures or with excess substrate, or both, because of the low reactivity of alkyl C–H bonds. Here we report a new iridium system comprising 2-anilino-1,10-phenanthroline as ligand that catalyzes the borylation of alkyl C–H bonds with little to no induction period and with high reaction rates. This superior activation and reactivity profile of 2-aminophenanthroline catalysts leads to broader scope of the reaction, including those with sensitive reactants, such as epoxides and glycosidic acetals, enhanced diastereoselectivity, and higher yields of borylated products. These catalysts also enable the borylation of alkanes, amines, and ethers at room temperature for the first time. Mechanistic studies imply that facile N-borylation occurs under the reaction conditions, and that iridium complexes containing N-boryl aminophenanthrolines are competent precatalysts for the reaction.